Information:
Fel:
ID
34229
Beskrivning
Non-invasive and Invasive Assessment of Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01823809
Länk
https://clinicaltrials.gov/show/NCT01823809
Nyckelord
Versioner (1)
- 2019-01-15 2019-01-15 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
15 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Coronary Artery Disease NCT01823809
Eligibility Coronary Artery Disease NCT01823809
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT01823809
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
1. patients with stable angina pectoris with low to intermediate pre-test likelihood of cad;
boolean
ID.2
Item
2. no previous history of cad;
boolean
ID.3
Item
3. obstructive stenosis (≥50% luminal narrowing) on msct coronary angiography; 4.informed consent.
boolean
ID.4
Item
1. patients with a previous history of cad;
boolean
ID.5
Item
2. patients with contraindications for msct: a.cardiac rhythms other than sinus rhythm, b.pregnancy, c.allergy for contrast medium, d.renal failure (estimated glomerular filtration rate (egfr) < 50ml/min), e.resting heart rate >75 bpm plus contra-indications for beta-blockade, f. weight >100 kilograms;
boolean
ID.6
Item
3. contraindications for cardiac magnetic resonance (cmr) imaging: a.mr-incompatible implants, b. claustrophobia, c. contraindications for adenosine: i. known or suspected hypersensitivity to adenosine, ii. known or suspected bronchoconstrictive or bronchospastic disease, iii. 2nd or 3rd degree atrioventricular (av) block, iv. sinus bradycardia (heart rate < 45 bpm), v. systemic arterial hypotension (<90 mmhg).
boolean
ID.7
Item
d. contraindications for gadolinium: i. renal failure (estimated egfr <30 ml/min);
boolean
ID.8
Item
4. no informed consent.
boolean